Delivery Order SPE2DU25D5338-SPE2DU26FX680
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,785.54 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child order under a larger Indefinite Delivery Contract vehicle with a ceiling value of $999,999,999.00 that runs through December 2026. The delivery order is scheduled for completion by January 7, 2026, with performance occurring at the company's corporate office...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $93,276.40 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with no set-aside, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award valued at $5,498.88 from the Defense Logistics Agency on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order represents a child contract under the larger pharmaceutical supply framework and was awarded without set-aside designation, indicating open competition. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $74,044.06 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside, competitively awarded contract represents a single delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The work will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $6,156.96 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $744,323.91 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 8, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,545.28 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026. This competitively awarded, non-set-aside contract features firm fixed pricing and carries an ultimate completion date of January 8, 2026. The delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as...
- SPE2DU25D5338Indefinite Delivery Contract
- SPE2DU25D5338-SPE2DU26FX680Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,789.00 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was issued without a set-aside designation, indicating open and competitive award. The contract is a child order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, medical devices, and other healthcare commodities across multiple therapeutic domains. This delivery order represents a routine transaction within the company's established relationship with DLA for pharmaceutical supply chain support to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/6/26 |